by According to Precedence Research, during the forecast period of 2022 to 2030, the global neurostimulation devices market is estimated to develop at a compound annual growth rate (CAGR) of 11.57%. The global neurostimulation devices market was valued at USD 8.93 billion in 2021, and it is predicted to exceed USD 23.9 billion by 2030. The study investigates several elements and their consequences on the growth of the neurostimulation devices market.
Download Free Sample Copy with TOC@ https://www.precedenceresearch.com/sample/1853
This report focuses on neurostimulation devices market volume and value at the global level, regional level and company level. From a global perspective, this report represents overall neurostimulation devices market size by analyzing historical data and future prospect. Regionally, this report focuses on several key regions: North America, Europe, Middle East & Africa, Latin America, etc.
Report Scope of the Hormone Replacement Therapy Market
| Report Coverage | Details |
| Market Size by 2030 | USD 23.9 Billion |
| Growth Rate from 2022 to 2030 | CAGR of 11.57% |
| North America Market Share in 2021 | 61% |
| Spinal Cord Trigger Product Segment Market Share in 2021 | 56% |
| Base Year | 2021 |
| Forecast Period | 2022 to 2030 |
| Segments Covered | Technology, Disease Pathology, Product, Application, End Users, Geography |
The research report includes specific segments by region (country), by company, by all segments. This study provides information about the growth and revenue during the historic and forecasted period of 2017 to 2030. Understanding the segments helps in identifying the importance of different factors that aid the market growth.
In-Depth Analysis on Competitive Landscape
The report sheds light on leading manufacturers of neurostimulation devices, along with their detailed profiles. Essential and up-to-date data related to market performers who are principally engaged in the production of neurostimulation devices has been brought with the help of a detailed dashboard view. Market share analysis and comparison of prominent players provided in the report permits report readers to take preemptive steps in advancing their businesses.
Company profiles have been included in the report, which include essentials such as product portfolio, key strategies, along with all-inclusive SWOT analysis on each player. Company presence is mapped and presented through a matrix for all the prominent players, thus providing readers with actionable insights, which helps in thoughtfully presenting market status and predicting the competition level in the neurostimulation devices market.
Some of the prominent players in the neurostimulation devices market include:
- Medtronic PLC
- Cyberonics
- Boston Scientific Corp.
- St. Jude Medical, Inc.
- Nevro Corp.
- MicroPort Scientific Corporation (China),
- Kaneka Corp. (Japan)
- Integer Holdings Corporation
- BALT (France)
- Perflow Medical
- Phenox GmbH (Germany)
- Sensome (France)
Ask Here For More Customization Study@ https://www.precedenceresearch.com/customization/1853
Segments Covered in the Report
By Technology
- Aneurysm coiling & embolization devices
- Embolic coils
- Bare detachable coils
- Coated detachable coils
- Flow diversion devices
- Liquid embolic agents
- Embolic coils
- Cerebral balloon angioplasty & Stenting systems
- Carotid artery stents
- Embolic protection devices
- Balloon catheters
- Support devices
- Microcatheters
- Guidewires
- Neurothrombectomy devices
- Clot retrievals
- Suction & aspiration devices
- Snares
By Disease Pathology
- Ischemic Strokes
- Cerebral Aneuryms
- Carotid Artery Stenosis
- Arteriovenous Malformations and Fistulas
- Other Diseases
By Product
- Spinal Cord Stimulator
- Deep Brain Stimulator
- Sacral Nerve Stimulator
- Vagus Nerve Stimulator
- Gastric Electric Stimulator
By Application
- Pain Management
- Epilepsy
- Essential Tremor
- Urinary and Fecal Incontinence
- Depression
- Dystonia
- Gastroparesis
- Parkinson’s Disease
- Others
By End Users
- Hospitals & Surgical Centers
- Ambulatory Care Centers
- Research Laboratories & Academic Institutes
Regional Segmentation
- Asia-Pacific [China, Southeast Asia, India, Japan, Korea, Western Asia]
- Europe [Germany, UK, France, Italy, Russia, Spain, Netherlands, Turkey, Switzerland]
- North America [United States, Canada, Mexico]
- South America [Brazil, Argentina, Columbia, Chile, Peru]
- Middle East & Africa [GCC, North Africa, South Africa]
Some of the important ones are:
- What can be the best investment choices for venturing into new product and service lines?
- What value propositions should businesses aim at while making new research and development funding?
- Which regulations will be most helpful for stakeholders to boost their supply chain network?
- Which regions might see the demand maturing in certain segments in near future?
- What are the some of the best cost optimization strategies with vendors that some well-entrenched players have gained success with?
- Which are the key perspectives that the C-suite are leveraging to move businesses to new growth trajectory?
- Which government regulations might challenge the status of key regional markets?
- How will the emerging political and economic scenario affect opportunities in key growth areas?
- What are some of the value-grab opportunities in various segments?
- What will be the barrier to entry for new players in the market?
Table of Contents
Chapter 1. Introduction
1.1. Research Objective
1.2. Scope of the Study
1.3. Definition
Chapter 2. Research Methodology
2.1. Research Approach
2.2. Data Sources
2.3. Assumptions & Limitations
Chapter 3. Executive Summary
3.1. Market Snapshot
Chapter 4. Market Variables and Scope
4.1. Introduction
4.2. Market Classification and Scope
4.3. Industry Value Chain Analysis
4.3.1. Raw Material Procurement Analysis
4.3.2. Sales and Distribution Channel Analysis
4.3.3. Downstream Buyer Analysis
Chapter 5. COVID 19 Impact on Neurostimulation Devices Market
5.1. COVID-19 Landscape: Neurostimulation Devices Industry Impact
5.2. COVID 19 – Impact Assessment for the Industry
5.3. COVID 19 Impact: Global Major Government Policy
5.4. Market Trends and Opportunities in the COVID-19 Landscape
Chapter 6. Market Dynamics Analysis and Trends
6.1. Market Dynamics
6.1.1. Market Drivers
6.1.2. Market Restraints
6.1.3. Market Opportunities
6.2. Porter’s Five Forces Analysis
6.2.1. Bargaining power of suppliers
6.2.2. Bargaining power of buyers
6.2.3. Threat of substitute
6.2.4. Threat of new entrants
6.2.5. Degree of competition
Chapter 7. Competitive Landscape
7.1.1. Company Market Share/Positioning Analysis
7.1.2. Key Strategies Adopted by Players
7.1.3. Vendor Landscape
7.1.3.1. List of Suppliers
7.1.3.2. List of Buyers
Chapter 8. Global Neurostimulation Devices Market, By Technology
8.1. Neurostimulation Devices Market, by January, 2022-2030
8.1.1. Aneurysm coiling & embolization devices
8.1.1.1. Market Revenue and Forecast (2017-2030)
8.1.2. Cerebral balloon angioplasty & Stenting systems
8.1.2.1. Market Revenue and Forecast (2017-2030)
8.1.3. Support devices
8.1.3.1. Market Revenue and Forecast (2017-2030)
8.1.4. Neurothrombectomy devices
8.1.4.1. Market Revenue and Forecast (2017-2030)
Chapter 9. Global Neurostimulation Devices Market, By Disease Pathology
9.1. Neurostimulation Devices Market, by February, 2022-2030
9.1.1. Ischemic Strokes
9.1.1.1. Market Revenue and Forecast (2017-2030)
9.1.2. Cerebral Aneuryms
9.1.2.1. Market Revenue and Forecast (2017-2030)
9.1.3. Carotid Artery Stenosis
9.1.3.1. Market Revenue and Forecast (2017-2030)
9.1.4. Arteriovenous Malformations and Fistulas
9.1.4.1. Market Revenue and Forecast (2017-2030)
9.1.5. Other Diseases
9.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 10. Global Neurostimulation Devices Market, By Product
10.1. Neurostimulation Devices Market, by March, 2022-2030
10.1.1. Spinal Cord Stimulator
10.1.1.1. Market Revenue and Forecast (2017-2030)
10.1.2. Deep Brain Stimulator
10.1.2.1. Market Revenue and Forecast (2017-2030)
10.1.3. Sacral Nerve Stimulator
10.1.3.1. Market Revenue and Forecast (2017-2030)
10.1.4. Vagus Nerve Stimulator
10.1.4.1. Market Revenue and Forecast (2017-2030)
10.1.5. Gastric Electric Stimulator
10.1.5.1. Market Revenue and Forecast (2017-2030)
Chapter 11. Global Neurostimulation Devices Market, By Application
11.1. Neurostimulation Devices Market, by April, 2022-2030
11.1.1. Pain Management
11.1.1.1. Market Revenue and Forecast (2017-2030)
11.1.2. Epilepsy
11.1.2.1. Market Revenue and Forecast (2017-2030)
11.1.3. Essential Tremor
11.1.3.1. Market Revenue and Forecast (2017-2030)
11.1.4. Urinary and Fecal Incontinence
11.1.4.1. Market Revenue and Forecast (2017-2030)
11.1.5. Depression
11.1.5.1. Market Revenue and Forecast (2017-2030)
11.1.6. Dystonia
11.1.6.1. Market Revenue and Forecast (2017-2030)
11.1.7. Gastroparesis
11.1.7.1. Market Revenue and Forecast (2017-2030)
11.1.8. Parkinson’s Disease
11.1.8.1. Market Revenue and Forecast (2017-2030)
11.1.9. Others
11.1.9.1. Market Revenue and Forecast (2017-2030)
Chapter 12. Global Neurostimulation Devices Market, By End Users
12.1. Neurostimulation Devices Market, by May, 2022-2030
12.1.1. Hospitals & Surgical Centers
12.1.1.1. Market Revenue and Forecast (2017-2030)
12.1.2. Ambulatory Care Centers
12.1.2.1. Market Revenue and Forecast (2017-2030)
12.1.3. Research Laboratories & Academic Institutes
12.1.3.1. Market Revenue and Forecast (2017-2030)
Chapter 13. Global Neurostimulation Devices Market, Regional Estimates and Trend Forecast
13.1. North America
13.1.1. Market Revenue and Forecast, by January (2017-2030)
13.1.2. Market Revenue and Forecast, by February (2017-2030)
13.1.3. Market Revenue and Forecast, by March (2017-2030)
13.1.4. Market Revenue and Forecast, by April (2017-2030)
13.1.5. Market Revenue and Forecast, by May (2017-2030)
13.1.6. U.S.
13.1.6.1. Market Revenue and Forecast, by January (2017-2030)
13.1.6.2. Market Revenue and Forecast, by February (2017-2030)
13.1.6.3. Market Revenue and Forecast, by March (2017-2030)
13.1.6.4. Market Revenue and Forecast, by April (2017-2030)
13.1.7. Market Revenue and Forecast, by May (2017-2030)
13.1.8. Rest of North America
13.1.8.1. Market Revenue and Forecast, by January (2017-2030)
13.1.8.2. Market Revenue and Forecast, by February (2017-2030)
13.1.8.3. Market Revenue and Forecast, by March (2017-2030)
13.1.8.4. Market Revenue and Forecast, by April (2017-2030)
13.1.8.5. Market Revenue and Forecast, by May (2017-2030)
13.2. Europe
13.2.1. Market Revenue and Forecast, by January (2017-2030)
13.2.2. Market Revenue and Forecast, by February (2017-2030)
13.2.3. Market Revenue and Forecast, by March (2017-2030)
13.2.4. Market Revenue and Forecast, by April (2017-2030)
13.2.5. Market Revenue and Forecast, by May (2017-2030)
13.2.6. UK
13.2.6.1. Market Revenue and Forecast, by January (2017-2030)
13.2.6.2. Market Revenue and Forecast, by February (2017-2030)
13.2.6.3. Market Revenue and Forecast, by March (2017-2030)
13.2.7. Market Revenue and Forecast, by April (2017-2030)
13.2.8. Market Revenue and Forecast, by May (2017-2030)
13.2.9. Germany
13.2.9.1. Market Revenue and Forecast, by January (2017-2030)
13.2.9.2. Market Revenue and Forecast, by February (2017-2030)
13.2.9.3. Market Revenue and Forecast, by March (2017-2030)
13.2.10. Market Revenue and Forecast, by April (2017-2030)
13.2.11. Market Revenue and Forecast, by May (2017-2030)
13.2.12. France
13.2.12.1. Market Revenue and Forecast, by January (2017-2030)
13.2.12.2. Market Revenue and Forecast, by February (2017-2030)
13.2.12.3. Market Revenue and Forecast, by March (2017-2030)
13.2.12.4. Market Revenue and Forecast, by April (2017-2030)
13.2.13. Market Revenue and Forecast, by May (2017-2030)
13.2.14. Rest of Europe
13.2.14.1. Market Revenue and Forecast, by January (2017-2030)
13.2.14.2. Market Revenue and Forecast, by February (2017-2030)
13.2.14.3. Market Revenue and Forecast, by March (2017-2030)
13.2.14.4. Market Revenue and Forecast, by April (2017-2030)
13.2.15. Market Revenue and Forecast, by May (2017-2030)
13.3. APAC
13.3.1. Market Revenue and Forecast, by January (2017-2030)
13.3.2. Market Revenue and Forecast, by February (2017-2030)
13.3.3. Market Revenue and Forecast, by March (2017-2030)
13.3.4. Market Revenue and Forecast, by April (2017-2030)
13.3.5. Market Revenue and Forecast, by May (2017-2030)
13.3.6. India
13.3.6.1. Market Revenue and Forecast, by January (2017-2030)
13.3.6.2. Market Revenue and Forecast, by February (2017-2030)
13.3.6.3. Market Revenue and Forecast, by March (2017-2030)
13.3.6.4. Market Revenue and Forecast, by April (2017-2030)
13.3.7. Market Revenue and Forecast, by May (2017-2030)
13.3.8. China
13.3.8.1. Market Revenue and Forecast, by January (2017-2030)
13.3.8.2. Market Revenue and Forecast, by February (2017-2030)
13.3.8.3. Market Revenue and Forecast, by March (2017-2030)
13.3.8.4. Market Revenue and Forecast, by April (2017-2030)
13.3.9. Market Revenue and Forecast, by May (2017-2030)
13.3.10. Japan
13.3.10.1. Market Revenue and Forecast, by January (2017-2030)
13.3.10.2. Market Revenue and Forecast, by February (2017-2030)
13.3.10.3. Market Revenue and Forecast, by March (2017-2030)
13.3.10.4. Market Revenue and Forecast, by April (2017-2030)
13.3.10.5. Market Revenue and Forecast, by May (2017-2030)
13.3.11. Rest of APAC
13.3.11.1. Market Revenue and Forecast, by January (2017-2030)
13.3.11.2. Market Revenue and Forecast, by February (2017-2030)
13.3.11.3. Market Revenue and Forecast, by March (2017-2030)
13.3.11.4. Market Revenue and Forecast, by April (2017-2030)
13.3.11.5. Market Revenue and Forecast, by May (2017-2030)
13.4. MEA
13.4.1. Market Revenue and Forecast, by January (2017-2030)
13.4.2. Market Revenue and Forecast, by February (2017-2030)
13.4.3. Market Revenue and Forecast, by March (2017-2030)
13.4.4. Market Revenue and Forecast, by April (2017-2030)
13.4.5. Market Revenue and Forecast, by May (2017-2030)
13.4.6. GCC
13.4.6.1. Market Revenue and Forecast, by January (2017-2030)
13.4.6.2. Market Revenue and Forecast, by February (2017-2030)
13.4.6.3. Market Revenue and Forecast, by March (2017-2030)
13.4.6.4. Market Revenue and Forecast, by April (2017-2030)
13.4.7. Market Revenue and Forecast, by May (2017-2030)
13.4.8. North Africa
13.4.8.1. Market Revenue and Forecast, by January (2017-2030)
13.4.8.2. Market Revenue and Forecast, by February (2017-2030)
13.4.8.3. Market Revenue and Forecast, by March (2017-2030)
13.4.8.4. Market Revenue and Forecast, by April (2017-2030)
13.4.9. Market Revenue and Forecast, by May (2017-2030)
13.4.10. South Africa
13.4.10.1. Market Revenue and Forecast, by January (2017-2030)
13.4.10.2. Market Revenue and Forecast, by February (2017-2030)
13.4.10.3. Market Revenue and Forecast, by March (2017-2030)
13.4.10.4. Market Revenue and Forecast, by April (2017-2030)
13.4.10.5. Market Revenue and Forecast, by May (2017-2030)
13.4.11. Rest of MEA
13.4.11.1. Market Revenue and Forecast, by January (2017-2030)
13.4.11.2. Market Revenue and Forecast, by February (2017-2030)
13.4.11.3. Market Revenue and Forecast, by March (2017-2030)
13.4.11.4. Market Revenue and Forecast, by April (2017-2030)
13.4.11.5. Market Revenue and Forecast, by May (2017-2030)
13.5. Latin America
13.5.1. Market Revenue and Forecast, by January (2017-2030)
13.5.2. Market Revenue and Forecast, by February (2017-2030)
13.5.3. Market Revenue and Forecast, by March (2017-2030)
13.5.4. Market Revenue and Forecast, by April (2017-2030)
13.5.5. Market Revenue and Forecast, by May (2017-2030)
13.5.6. Brazil
13.5.6.1. Market Revenue and Forecast, by January (2017-2030)
13.5.6.2. Market Revenue and Forecast, by February (2017-2030)
13.5.6.3. Market Revenue and Forecast, by March (2017-2030)
13.5.6.4. Market Revenue and Forecast, by April (2017-2030)
13.5.7. Market Revenue and Forecast, by May (2017-2030)
13.5.8. Rest of LATAM
13.5.8.1. Market Revenue and Forecast, by January (2017-2030)
13.5.8.2. Market Revenue and Forecast, by February (2017-2030)
13.5.8.3. Market Revenue and Forecast, by March (2017-2030)
13.5.8.4. Market Revenue and Forecast, by April (2017-2030)
13.5.8.5. Market Revenue and Forecast, by May (2017-2030)
Chapter 14. Company Profiles
14.1. Medtronic PLC
14.1.1. Company Overview
14.1.2. Product Offerings
14.1.3. Financial Performance
14.1.4. Recent Initiatives
14.2. Cyberonics
14.2.1. Company Overview
14.2.2. Product Offerings
14.2.3. Financial Performance
14.2.4. Recent Initiatives
14.3. Boston Scientific Corp.
14.3.1. Company Overview
14.3.2. Product Offerings
14.3.3. Financial Performance
14.3.4. Recent Initiatives
14.4. St. Jude Medical, Inc.
14.4.1. Company Overview
14.4.2. Product Offerings
14.4.3. Financial Performance
14.4.4. Recent Initiatives
14.5. Nevro Corp.
14.5.1. Company Overview
14.5.2. Product Offerings
14.5.3. Financial Performance
14.5.4. Recent Initiatives
14.6. MicroPort Scientific Corporation
14.6.1. Company Overview
14.6.2. Product Offerings
14.6.3. Financial Performance
14.6.4. Recent Initiatives
14.7. Kaneka Corp
14.7.1. Company Overview
14.7.2. Product Offerings
14.7.3. Financial Performance
14.7.4. Recent Initiatives
14.8. Integer Holdings Corporation
14.8.1. Company Overview
14.8.2. Product Offerings
14.8.3. Financial Performance
14.8.4. Recent Initiatives
14.9. BALT
14.9.1. Company Overview
14.9.2. Product Offerings
14.9.3. Financial Performance
14.9.4. Recent Initiatives
14.10. Perflow Medical
14.10.1. Company Overview
14.10.2. Product Offerings
14.10.3. Financial Performance
14.10.4. Recent Initiatives
Chapter 15. Research Methodology
15.1. Primary Research
15.2. Secondary Research
15.3. Assumptions
Chapter 16. Appendix
16.1. About Us
16.2. Glossary of Terms
Buy This Premium Research Report Click Here@ https://www.precedenceresearch.com/checkout/1853
About Us
Precedence Research is a Canada/India based company and one of the leading providers of strategic market insights. We offer executive-level blueprints of markets and solutions beyond flagship surveys. Our repository covers consultation, syndicated market studies, and customized research reports. Through our services we aim at connecting an organization’s goal with lucrative prospects globally.
From gauging investment feasibility to uncovering hidden growth opportunities, our market studies cover in-depth analysis, which also is interspersed with relevant statistics. Recommendation are often enclosed within our reports with the sole intent of enabling organizations achieve mission-critical success.
Contact Us:
Precedence Research
Apt 1408 1785 Riverside Drive Ottawa, ON, K1G 3T7, Canada
Call: +1 9197 992 333
Email: sales@precedenceresearch.com
Website: https://www.precedenceresearch.com
